News
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...
Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...
5d
GlobalData on MSNFDA grants 510(k) clearance for Tempus AI’s ejection fraction softwareThe US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
8mon
Health on MSNWhat To Know about Systolic Congestive Heart FailureMedically reviewed by Christopher Lee, MDSystolic congestive heart failure, or systolic heart failure, is a type of heart failure that involves the left side of the heart. As the left side of the ...
8d
MedPage Today on MSNFinerenone Gets Expanded FDA Approval in Heart FailureThe FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.
The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...
Q: Can you tell me about ejection fractions? My wife’s heart doctor recently told us that her heart is weak, and she has a low ejection fraction. He did not discuss this much, but he has put her ...
The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results